---
schema_version: "secwatch.filing_event.v1"
accession: "0001185185-23-000073"
form_type: "8-K"
ticker: "STEX"
cik: "0001530766"
company_name: "Streamex Corp."
filed_at: "2023-01-26T23:59:59+00:00"
generated_at: "2026-06-20T08:10:37.619750+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# BioSig raises $160k via stock and warrant offering

## Summary
- Sold 196,872 shares at $0.8127 per share to institutional/accredited investors.
- Issued warrants to purchase 98,436 shares at $0.7502 per share (50% coverage).
- Warrants exercisable six months after issuance, expiring 5.5 years from issuance.
- Total aggregate consideration ~$159,998 from the offering.
- Exempt from registration under Section 4(a)(2) and Regulation D.

## SEC filing metadata
- accession: 0001185185-23-000073
- form_type: 8-K
- ticker: STEX
- cik: 0001530766
- company_name: Streamex Corp.
- filed_at: 2023-01-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1530766/000118518523000073/0001185185-23-000073-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1530766/000118518523000073/biosig20230125_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001185185-23-000073
- JSON: https://secwatch.observer/filing/0001185185-23-000073.json
- Plain text: https://secwatch.observer/filing/0001185185-23-000073.txt

## Key facts
- Material Agreements
  Streamex Corp. entered into Securities Purchase Agreement with certain institutional and accredited investors valued at aggregate consideration of $159,997.87 (effective 2023-01-25).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: certain institutional and accredited investors
  - Value: aggregate consideration of $159,997.87
  - Effective: 2023-01-25
  source text: On January 25, 2023, BioSig Technologies, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain institutional and accredited investors (the “Investors”), pursuant to which the Company sold to the Investors an aggregate of 196,872 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”) at a purchase price of $0.8127 per share, and warrants (the “Warrants”) to purchase up to 98,436 shares of Common Stock (the “Warrant Shares” and together with the Shares and Warrants, the “Securities”), at an exercise price of $0.7502 per share, that will become exercisable six months after the date of issuance and will expire five and one-half years following the date of issuance, in exchange for aggregate consideration of $159,997.87.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1530766/000118518523000073/0001185185-23-000073-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.